Unraveling the ROS-Inflammation-Immune Balance: A New Perspective on Aging and Disease
Aging and disease · 2025
DOI: 10.14336/ad.2024.1253 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Aging and disease, 2025. Verfasst von Sihang Fang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hosp…. Hauptthemen laut MEDLINE: Aging, Reactive Oxygen Species, Inflammation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Increased entropy is a common cause of disease and aging. Lifespan entropy is the overall increase in disorder caused by a person over their lifetime. Aging leads to the excessive production of reactive oxygen species (ROS), which damage the antioxidant system and disrupt redox balance. Organ aging causes chronic inflammation, disrupting the balance of proinflammatory and anti-inflammatory factors. Inflammaging, which is a chronic low-grade inflammatory state, is activated by oxidative stress and can lead to immune system senescence. During this process, entropy increases significantly as the body transitions from a state of low order to high disorder. However, the connection among inflammation, aging, and immune system activity is still not fully understood. This review introduces the idea of the ROS-inflammation-immune balance for the first time and suggests that this balance may be connected to aging and the development of age-related diseases. We also explored how the balance of these three factors controls and affects age-related diseases. Moreover, imbalance in the relationship described above disrupts the regular structures of cells and alters their functions, leading to cellular damage and the emergence of a disorganized state marked by increased entropy. Maintaining a low entropy state is crucial for preventing and reversing aging processes. Consequently, we examined the current preclinical evidence for antiaging medications that target this balance. Ultimately, comprehending the intricate relationships between these three factors and the risk of age-related diseases in organisms will aid in the development of clinical interventions that promote long-term health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology of National Health Commission, Bei…
- Respiratory Department, Beijing Children's Hospital, Capital Medical University, China National Clinical Research Center of Respiratory Diseases, National Center for Children's Health, Beijing, China.
- Department of Clinical Laboratory, the Seventh Medical Center of PLA General Hospital, Beijing, China.
- Department of Biochemistry and Molecular Biology, The Key Laboratory of Neural and Vascular Biology, Ministry of Education of China, Hebei Medical University, Shijiazhuang, Hebei, China.
Zitieren
APA
Fang, S., Jiang, M., Jiao, J., Zhao, H., Liu, D., Gao, D., Wang, T., Yang, Z., & Yuan, H. (2025). Unraveling the ROS-Inflammation-Immune Balance: A New Perspective on Aging and Disease. Aging and disease, 0. https://doi.org/10.14336/ad.2024.1253
Vancouver
Fang S, Jiang M, Jiao J, Zhao H, Liu D, Gao D, et al. Unraveling the ROS-Inflammation-Immune Balance: A New Perspective on Aging and Disease. Aging and disease. 2025:0. doi:10.14336/ad.2024.1253
BibTeX
@article{Fang2025,
author = {Fang, Sihang and Jiang, Mingjun and Jiao, Juan and Zhao, Hongye and Liu, Dizhi and Gao, Danni and Wang, Tenger and Yang, Ze and Yuan, Huiping},
title = {Unraveling the ROS-Inflammation-Immune Balance: A New Perspective on Aging and Disease},
journal = {Aging and disease},
year = {2025},
pages = {0},
doi = {10.14336/ad.2024.1253}
}
EUVIMED